AstraZeneca Resumes COVID-19 Trials After Halt Over Adverse Reaction
September 12, 2020 at 14:56 PM EDT
AstraZeneca announced on Saturday that its Phase 3 COVID-19 study would resume, days after a participant fell ill. The company stated that the Medicines Health Regulatory Authority had given the green light to resume the trials conducted.
